Innovative aiTBS therapy shortens treatment duration for bipolar disorder

FHS
July 11, 2024
5:38 pm

A potential new treatment for bipolar disorder (BP) that significantly shortens treatment time has emerged, following a randomized clinical trial using accelerated intermittent theta burst stimulation (aiTBS).

MorphoSys AG Reports First Quarter 2024 Financial Results – Biotech Investments

EQS-News: MorphoSys AG / Key word(s): Quarterly / Interim Statement MorphoSys AG Reports First Quarter 2024 Financial Results 29.04.2024 / 22:01 CET/CEST The issuer is

April 30, 2024

Crossject secures funding from French Government for needle-free platform – Pharmaceutical Technology

Crossject’s single-use prefilled device propels medicine through the skin in less than one tenth of a second. Credit: Crossject. French company Crossject has secured €6.9m

July 14, 2024

Researchers explore immunomodulating targets for improving glioblastoma therapies

Researchers have delved into the intricate heterogeneity of glioblastoma, a notoriously aggressive brain tumor, using advanced single-cell RNA sequencing and innovative zebrafish avatars. Their findings

October 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.